[Prognostic significance red blood cell distribution width in myelodysplastic syndromes].

Chen, Y; Niu, T T; Shi, C; Zou, D B; Ouyang, G F; Mu, Q T; Jin, J

Chen, Y; Niu, T T; Shi, C; Zou, D B; Ouyang, G F; Mu, Q T; Jin, J.

Afiliação

Chen Y; Department of Hematology, Institute of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
Niu TT; Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo 315010, China.
Shi C; Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo 315010, China.
Zou DB; Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo 315010, China.
Ouyang GF; Department of Hematology, Ningbo First Hospital, Ningbo 315010, China.
Mu QT; Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo 315010, China.
Jin J; Department of Hematology, Institute of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.

Zhonghua Xue Ye Xue Za Zhi ; 43(8): 686-690, 2022 08 14.

Article em Zh | MEDLINE | ID: mdl-36709156

Assuntos

Síndromes Mielodisplásicas; Humanos; Prognóstico; Índices de Eritrócitos; Eritrócitos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google